IronBridge Private Wealth’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Other funds holding HAE
LCOV
LCP
IronBridge Private Wealth's HAE Position: Q1 2022 in Review
IronBridge Private Wealth sold out of Haemonetics (HAE) in Q1 2022, closing a stake of 623 shares — an estimated $33K sold.
IronBridge Private Wealth first reported a position in HAE in Q4 2020 and held it in 5 quarters. The position peaked at $119K in Q4 2020. 242 funds tracked by Wall St. Rank hold HAE as of Q1 2022.
- IronBridge Private Wealth reported no remaining Haemonetics position as of Q1 2022 after selling out during the quarter.
- IronBridge Private Wealth sold 623 Haemonetics shares in Q1 2022, an estimated $33K.
- IronBridge Private Wealth first reported a position in Haemonetics in Q4 2020 and held it in 5 quarters.
- IronBridge Private Wealth's Haemonetics position peaked at $119K in Q4 2020.
- 242 funds tracked by Wall St. Rank held Haemonetics as of Q1 2022.
Based on IronBridge Private Wealth's 13F filing for Q1 2022, filed 16 May 2022.